Immunovant Inc. (IMVT)
undefined
undefined%
At close: undefined
26.28
-0.17%
After-hours Dec 13, 2024, 05:19 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Revenue - - - - - - -
Cost of Revenue 231.00K 1.32M 1.23M 998.00K 21.00K - -
Gross Profit -231.00K -1.32M -1.23M -998.00K -21.00K - -
Operating Income -282.71M -198.47M -156.16M -107.79M -65.67M -450 -136.74M
Interest Income 24.95M 7.58M - - 625.00 - -
Pretax Income -258.77M -210.95M -156.81M -107.79M -66.29M -448 -136.74M
Net Income -259.34M -210.96M -156.73M -107.43M -66.39M -448 -136.74M
Selling & General & Admin 57.28M 48.02M 54.23M 39.51M 18.15M 448.00 1.48M
Research & Development 212.93M 160.26M 101.81M 68.60M 47.93M 25.73M 135.26M
Other Expenses 12.50M -253.00K -781.00K 328.00K 412.00K - -
Operating Expenses 282.71M 208.28M 156.03M 108.12M 66.08M 448.00 136.74M
Interest Expense - 12.48M 655.00K - 625.00K - -
Selling & Marketing Expenses - - - - - -2.69M -
Cost & Expenses 282.71M 208.28M 156.03M 108.12M 66.08M 448.00 136.74M
Income Tax 567.00K 9.00K -84.00K -358.00K 97.00K 19.00K -
Shares Outstanding (Basic) 138.10M 123.08M 109.68M 87.76M 43.20M 14.38M 10.00M
Shares Outstanding (Diluted) 138.10M 123.08M 109.68M 87.76M 43.20M 14.38M 10.00M
EPS (Basic) -1.88 -1.71 -1.43 -1.22 -1.54 - -13.68
EPS (Diluted) -1.88 -1.71 -1.43 -1.22 -1.54 - -13.67
EBITDA -269.98M -209.63M -155.58M -106.79M -65.64M -28.41M -
Depreciation & Amortization 231.00K 1.32M 1.23M 998.00K 21.00K 10.00K 136.74M